Henry Schein, Inc. (LON:0L3C)
London · Delayed Price · Currency is GBP · Price in USD 68.00
-1.46 (-2.10%)
At close: Sep 11, 2025
Henry Schein Market Cap
Henry Schein has a market cap or net worth of 6.14 billion as of September 16, 2025. Its market cap has decreased by -9.30% in one year.
Market Cap
6.14B
Enterprise Value
9.57B
Revenue
9.31B
Ranking
n/a
PE Ratio
21.63
Stock Price
68.00
Market Cap Chart
Since November 3, 1995, Henry Schein's market cap has increased from 263.64M to 6.14B, an increase of 2,227.33%. That is a compound annual growth rate of 11.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 6.14B | -10.97% |
| Dec 31, 2024 | 6.89B | -10.77% |
| Dec 29, 2023 | 7.72B | -14.04% |
| Dec 30, 2022 | 8.99B | 13.16% |
| Dec 31, 2021 | 7.94B | 13.56% |
| Dec 31, 2020 | 6.99B | -5.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.00B |
| GSK plc | 59.54B |
| Haleon | 31.92B |
| Smith & Nephew | 12.02B |
| ConvaTec Group | 4.70B |
| Hikma Pharmaceuticals | 3.56B |
| HUTCHMED (China) | 2.15B |
| Genus | 1.65B |